What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Searched for basg.
Safety warnings
|
messages in brief
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Safety warnings
|
messages in brief
|
30/05/2014
The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale
Safety warnings
|
messages in brief
|
30/04/2014
European Commission orders withdrawal of approval for metoclopramide-containing medicines in drop form with a concentration higher than 1 mg/ml.
Safety warnings
|
messages in brief
|
25/04/2014
Questions and answers about the stolen vials of Herceptin and other affected products
Safety warnings
|
Medicines
|
25/04/2014
Questions and answers about the stolen vials of Herceptin and other affected products
Safety warnings
|
messages in brief
|
17/04/2014
Situation Austria: currently only parallel marketed Italian Herceptin and Alimta are affected (as of 18.4.2014). The drug Herceptin is approved throughout Europe for the treatment of early breast cancer, metastatic breast cancer and metastatic…
Safety warnings
|
Medicines
|
17/04/2014
Update from the European Medicines Agency on stolen vials of Herceptin and other affected products
messages in brief
|
17/04/2014
Austrian "Summaries of Product Characteristics", "Labellings" and "Patient Information Leaflets" should now be submitted via PHAROS eService "Marketing Authorisation & Lifecycle Management of Medicines": https://eservices.basg.gv.at/ . If you are not…
Safety warnings
|
Medicines
|
16/04/2014
The European Medicines Agency received information that vials of Herceptin, a drug used to treat cancer, were adulterated and introduced into the legal distribution chain.
Safety warnings
|
messages in brief
|
16/04/2014
European Medicines Agency warns against counterfeit Herceptin